Literature DB >> 16135400

Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2.

Frederick Arce1, Omar Gätjens-Boniche, Ernesto Vargas, Berta Valverde, Cecilia Díaz.   

Abstract

Two hepatoma cell lines were incubated for 72 h with ATRA and its analog 13cisRA and according to MTT assay, Hep3B cells were highly susceptible whereas HepG2 cells were more resistant to the treatment. At the high concentration of 166 microM, retinoids were able to induce apoptosis in both cell lines and the highest effect was observed in HepG2 cells treated with ATRA. TUNEL-based photometric ELISA showed that at the same retinoid concentration tested by flow cytometry, both cell lines showed apoptosis whereas plasma membranes were not significantly disrupted. Inhibitors of apoptosis Bcl-xL and survivin were downregulated in Hep3B cells by treatment with both retinoids. Bax, a pro-apoptotic protein, was not significantly upregulated in Hep3B cells, but was slightly increased in HepG2 cells treated with 13cisRA. Both procaspase-3 and procaspase-8 were cleaved in Hep3B cells, suggesting apoptosis could be triggered through the extrinsic pathway. In the case of HepG2 cells, lack of caspase activation suggests a mechanism dependent on other kind of proteases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135400     DOI: 10.1016/j.canlet.2005.06.047

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug.

Authors:  Akhayacatra Chinsriwongkul; Ponwanit Chareanputtakhun; Tanasait Ngawhirunpat; Theerasak Rojanarata; Warisada Sila-on; Uracha Ruktanonchai; Praneet Opanasopit
Journal:  AAPS PharmSciTech       Date:  2011-12-14       Impact factor: 3.246

2.  A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways.

Authors:  Dayun Yang; Wensong Luo; Jichuang Wang; Min Zheng; Xin-Hua Liao; Nan Zhang; Wenxian Lu; Long Wang; Ai-Zheng Chen; Wen-Guo Wu; Hekun Liu; Shi-Bin Wang; Xiao Zhen Zhou; Kun Ping Lu
Journal:  J Control Release       Date:  2017-11-21       Impact factor: 9.776

3.  Role of retinoic acid in the modulation of benzo(a)pyrene-DNA adducts in human hepatoma cells: implications for cancer prevention.

Authors:  Guo-Dong Zhou; Molly Richardson; Inayat S Fazili; Jianbo Wang; Kirby C Donnelly; Fen Wang; Brad Amendt; Bhagavatula Moorthy
Journal:  Toxicol Appl Pharmacol       Date:  2010-10-01       Impact factor: 4.219

4.  Therapeutic effects of all trans-retinoic acid combined with transarterial chemoembolization on Walker-256 hepatoma in rats.

Authors:  Jianlin Fang; Chuansheng Zheng; Hongfang Tao; Hui Zhao; Jianzhuang Ren; Gansheng Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

5.  Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study.

Authors:  Lesley M Butler; Joyce Yongxu Huang; Renwei Wang; Mao-Jun Lee; Chung S Yang; Yu-Tang Gao; Jian-Min Yuan
Journal:  Am J Epidemiol       Date:  2015-02-21       Impact factor: 4.897

6.  Increased expression of Profilin potentiates chemotherapeutic agent-mediated tumour regression.

Authors:  Shashank Saurav; Sunil Kumar Manna
Journal:  Br J Cancer       Date:  2022-01-12       Impact factor: 9.075

7.  The antiestrogen 4-hydroxytamoxifen protects against isotretinoin-induced permeability transition and bioenergetic dysfunction of liver mitochondria: comparison with tamoxifen.

Authors:  Filomena S G Silva; Mariana P C Ribeiro; Maria S Santos; Petronila Rocha-Pereira; Alice Santos-Silva; José B A Custódio
Journal:  J Bioenerg Biomembr       Date:  2013-06-19       Impact factor: 2.945

8.  Anti-tumor effect of all-trans retinoic acid loaded polymeric micelles in solid tumor bearing mice.

Authors:  Narin Chansri; Shigeru Kawakami; Masayuki Yokoyama; Tatsuhiro Yamamoto; Pensri Charoensit; Mitsuru Hashida
Journal:  Pharm Res       Date:  2007-07-31       Impact factor: 4.200

9.  Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.

Authors:  Guo-Hua Qiu; Xiaojin Xie; Fang Xu; Xiaohao Shi; Yue Wang; Linhong Deng
Journal:  Cytotechnology       Date:  2014-07-08       Impact factor: 2.058

10.  All-trans-retinoic acid nanodisks.

Authors:  Katherine A Redmond; Thanh-Son Nguyen; Robert O Ryan
Journal:  Int J Pharm       Date:  2007-03-06       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.